Suppr超能文献

多态性与早发性乳腺癌

polymorphism and early-onset breast cancer.

作者信息

Icen-Taskin Irmak, Irtegun-Kandemir Sevgi, Munzuroglu Omer

机构信息

Department of Molecular Biology and Genetics, Faculty of Science and Art, Inonu University, Malatya, Turkey.

Department of Medical Biology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.

出版信息

J Res Med Sci. 2020 Mar 18;25:25. doi: 10.4103/jrms.JRMS_506_19. eCollection 2020.

Abstract

BACKGROUND

Breast cancer is the leading cause of cancer deaths among women. Early-onset breast cancer is well recognized as it clinically differs from old-age diagnosed breast neoplasms. polymorphism relates to the risk of breast neoplasms, but this relationship in Turkish early-onset breast cancer patients has not been investigated yet. We aimed to search the relationship between polymorphism and young Turkish breast cancer patients.

MATERIALS AND METHODS

Ninety-six female breast cancer patients who were ≤ 40 years of age and 96 healthy controls were enrolled in our study. Participants were genotyped by the hybridization probe system.

RESULTS

We identified that the genotype frequencies of were significantly different between controls and cases ( = 0.027). Participants carrying CG genotype had also reduced breast cancer risk (odds ratio = 0.4196, 95% confidence interval: 0.1941-0.9067, = 0.027). Our results revealed that there is an association between GG and CG + CC genotype groups with progesterone receptor (PgR) status ( = 0.0219).

CONCLUSION

Our findings indicate that the CG genotype is a protective factor against breast neoplasms. No other clinicopathologic parameters except for PgR status were found to be related to polymorphism in young Turkish breast cancer patients.

摘要

背景

乳腺癌是女性癌症死亡的主要原因。早发性乳腺癌已得到充分认识,因为其在临床上与老年诊断出的乳腺肿瘤不同。[基因]多态性与乳腺肿瘤风险相关,但土耳其早发性乳腺癌患者中的这种关系尚未得到研究。我们旨在探究[基因]多态性与年轻土耳其乳腺癌患者之间的关系。

材料与方法

96名年龄≤40岁的女性乳腺癌患者和96名健康对照者纳入我们的研究。参与者通过杂交探针系统进行基因分型。

结果

我们发现,[基因]的基因型频率在对照组和病例组之间存在显著差异(P = 0.027)。携带CG基因型的参与者患乳腺癌的风险也降低(优势比= 0.4196,95%置信区间:0.1941 - 0.9067,P = 0.027)。我们的结果显示,GG和CG + CC基因型组与孕激素受体(PgR)状态之间存在关联(P = 0.0219)。

结论

我们的研究结果表明,CG基因型是预防乳腺肿瘤的一个保护因素。在年轻土耳其乳腺癌患者中,除了PgR状态外,未发现其他临床病理参数与[基因]多态性相关。

相似文献

1
polymorphism and early-onset breast cancer.
J Res Med Sci. 2020 Mar 18;25:25. doi: 10.4103/jrms.JRMS_506_19. eCollection 2020.
2
Association between the rs1042522 polymorphism in and prostate cancer risk: An updated meta-analysis.
Chronic Dis Transl Med. 2017 May 25;3(2):95-104. doi: 10.1016/j.cdtm.2017.04.001. eCollection 2017 Jun 25.
3
Association of TP53 rs1042522 with cervical cancer in the sub-Saharan African population: a meta-analysis.
Trop Med Int Health. 2020 Jun;25(6):666-672. doi: 10.1111/tmi.13397. Epub 2020 Apr 16.
4
The gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese children.
Aging (Albany NY). 2017 Mar 8;9(3):852-859. doi: 10.18632/aging.101196.
6
gene rs1042522 allele G decreases neuroblastoma risk: a two-centre case-control study.
J Cancer. 2019 Jan 1;10(2):467-471. doi: 10.7150/jca.27482. eCollection 2019.
7
[Association and interaction of heat shock proteins B1 gene and tumor-suppressor protein p53 gene with chromosome damage levels among coke oven workers].
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Oct 6;50(10):900-906. doi: 10.3760/cma.j.issn.0253-9624.2016.10.012.
9
Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population.
Asian Pac J Cancer Prev. 2014;15(18):7955-8. doi: 10.7314/apjcp.2014.15.18.7955.
10
TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population.
J Mol Neurosci. 2019 Aug;68(4):679-687. doi: 10.1007/s12031-019-01330-y. Epub 2019 May 5.

引用本文的文献

2
The Genetic Changes of Hepatoblastoma.
Front Oncol. 2021 Jul 21;11:690641. doi: 10.3389/fonc.2021.690641. eCollection 2021.

本文引用的文献

1
Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors.
Breast Cancer Res Treat. 2019 Jun;175(2):479-485. doi: 10.1007/s10549-019-05168-1. Epub 2019 Feb 22.
2
Cancer statistics, 2019.
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
3
Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease.
J Res Med Sci. 2017 Dec 26;22:130. doi: 10.4103/jrms.JRMS_967_16. eCollection 2017.
4
Biology of breast cancer in young women.
Breast Cancer Res. 2014 Aug 27;16(4):427. doi: 10.1186/s13058-014-0427-5.
5
Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population.
Asian Pac J Cancer Prev. 2014;15(18):7955-8. doi: 10.7314/apjcp.2014.15.18.7955.
6
Opportunities for public health communication, intervention, and future research on breast cancer in younger women.
J Womens Health (Larchmt). 2013 Apr;22(4):293-8. doi: 10.1089/jwh.2012.4239. Epub 2013 Mar 20.
7
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.
Clin Cancer Res. 2012 Mar 1;18(5):1341-51. doi: 10.1158/1078-0432.CCR-11-2599. Epub 2012 Jan 18.
8
Fertility and reproductive considerations in premenopausal patients with breast cancer.
Cancer Control. 2010 Jul;17(3):162-72. doi: 10.1177/107327481001700304.
9
The first 30 years of p53: growing ever more complex.
Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723.
10
p53 polymorphisms: cancer implications.
Nat Rev Cancer. 2009 Feb;9(2):95-107. doi: 10.1038/nrc2584.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验